Transdermal CBD No Better Than Placebo for Drug-Resistant Focal Epilepsy
For adults with drug-resistant focal epilepsy, no difference in efficacy was observed at 12 weeks for adjunctive therapy with transdermal cannabidiol versus placebo.
Source: neurologyadvisor.com